The independent source for health policy research, polling, and news.
Environmental health professor Don Milton is studying how the flu — and other dangerous infections — are spread. The close quarters of dorm rooms and cafeterias at the University of Maryland provide him with a steady supply of research subjects.
President Donald Trump’s decision to stop paying cost-sharing reduction subsidies means the federal government will reduce its funding of the Basic Health Program that provides low-cost coverage to more than 800,000 low-income people in those two states.
The centers, which serve 27 million people, get about 20 percent of their funding from the federal government. But that revenue is slated to end on March 31.
Two women, 80 and 91, from opposite poles, agree on the art of aging.
Fentanyl, a significant cause of overdoses and deaths across the country, has begun showing up in California street drugs. State health officials have responded with a bold but controversial policy: paying for test strips so users can check their stash.
HHS officials sign off on a plan that could lock out for six months thousands of people who fail to get their paperwork done promptly.
With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
The state branded its Medicaid expansion with some key conservative policies, and officials and advocates across the country are keenly watching the results.
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo and Julie Appleby and Sarah Jane Tribble of Kaiser Health News discuss President Donald Trump’s promises to reduce drug prices in his first State of the Union Address. The panelists also discuss the departure of the director of the Centers for Disease Control and Prevention after conflict-of-interest reports and the efforts by some states to flout the Affordable Care Act.
Some mothers who smoke pot see it as a harmless remedy for everything from pain to postpartum depression. But doctors say the active ingredients in marijuana can be passed onto the baby and may affect developing nervous systems.
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?
While the federal health law made insurers cover the full cost of screening colonoscopies, consumers with a history of polyps who need more frequent tests may have to pick up some costs.
For more than 50 years, the program for the poor and sick has been required to ferry certain clients to and from medical appointments. But a few states have sought — and received — waivers to that rule.
Many eyes are on the Trump administration to see how officials respond to Idaho’s approach to health insurance, which flouts some aspects of the Affordable Care Act.
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
Popular DNA ancestry tests don’t always find what people expect. That’s because of how DNA rearranges itself when egg meets sperm — and the quirks of genetic databases.
California’s family leave program allows people to get time off to care for a new child or sick relative. The wage replacement rate rises this year.
Health care professionals increasingly collaborate with anti-abuse advocates to identify victims and ensure they get the help they need. One women’s center is opening a shelter on the campus of a large public hospital in Los Angeles.
Will efforts to expand the practice to Massachusetts, New York, New Jersey and Hawaii succeed this year?
